Lung cancer is cancer that starts in your lungs. It is the leading cause of cancer death among men and women. Finding lung cancer early before it spreads improves your chances of beating the disease.

Small Cell Lung Cancer (SCLC): Though less common, SCLC is characterized by its rapid growth and aggressive nature, making early detection even more critical. Shari's experience underscores the often ...

Small cell lung cancer (SCLC) is among the most aggressive, deadliest forms of lung cancer, yet it’s still too often ...

In small cell lung cancer (SCLC), the protein DLL3 is a promising target in the development of emerging therapies. In ...

Sue McCarthy shares her experience overcoming stage 3B lung cancer, reflecting on the impact of her diagnosis. After ...

Matthew Herper covers medical innovation — both its promise and its perils. The biotech firm Nuvalent said Tuesday that new data indicate its targeted drug zidesamtinib could help patients with a rare ...

Ibtrozi is a medicine called a kinase inhibitor that is used to treat a certain type of lung cancer called non-small-cell lung cancer (NSCLC) that is caused by an abnormal ROS1 gene. NSCLC is the most ...

The FDA approved the combination of lurbinectedin and atezolizumab as first-line maintenance treatment for certain adults ...

Dr. Prantesh Jain and Dr. Joshua Sabari delved into the numerous advances in NSCLC following 2025 ASCO, highlighting the REZILIENT-1 and NeoADAURA trials. Dr. Prantesh Jain and Dr. Joshua K. Sabari ...